We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+0%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$27.8B
AUM Growth
-$2.85B
(-9.3%)
Cap. Flow
-$2.84B
Cap. Flow
% of AUM
-10.23%
Top 10 Holdings %
Top 10 Hldgs %
14.66%
Holding
3,019
New
1,558
Increased
–
Reduced
1
Closed
1,460
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
APKT
ACME Packet Inc
APKT
|
+$236K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$954M |
| 2 |
Meta Platforms (Facebook)
META
|
+$912M |
| 3 |
Philip Morris
PM
|
+$671M |
| 4 |
Amazon
AMZN
|
+$530M |
| 5 |
NVIDIA
NVDA
|
+$490M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 0% |
| 2 | Consumer Discretionary | 0% |
| 3 | Consumer Staples | 0% |
| 4 | Energy | 0% |
| 5 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Idexx Laboratories
IDXX
$46.2B
| – | – |
-562,707
| Closed | -$63.4M |
|
502
International Flavors & Fragrances
IFF
$21.9B
| – | – |
-216,017
| Closed | -$30.9M |
|
|
BRSL
503
Brightstar Lottery PLC
BRSL
$2.03B
| – | – |
-32,613
| Closed | -$795K |
|
504
Insteel Industries
IIIN
$625M
| – | – |
-180,183
| Closed | -$6.53M |
|
505
IMAX
IMAX
$2.66B
| – | – |
-9,500
| Closed | -$275K |
|
506
Ingles Markets
IMKTA
$1.67B
| – | – |
-8,109
| Closed | -$321K |
|
|
IMOS
507
ChipMOS TECHNOLOGIES
IMOS
$1.83B
| – | – |
-28,497
| Closed | -$622K |
|
508
ING
ING
$102B
| – | – |
-950,615
| Closed | -$11.7M |
|
509
Inogen
INGN
$164M
| – | – |
-10,200
| Closed | -$611K |
|
510
Ingredion
INGR
$6.58B
| – | – |
-16,900
| Closed | -$2.25M |
|
511
Inovio Pharmaceuticals
INO
$69M
| – | – |
-20,009
| Closed | -$2.24M |
|
512
Intel
INTC
$513B
| – | – |
-10,317,804
| Closed | -$389M |
|
513
Intuit
INTU
$89B
| – | – |
-427,217
| Closed | -$47M |
|
514
Innoviva
INVA
$1.48B
| – | – |
-564,650
| Closed | -$6.21M |
|
515
Ionis Pharmaceuticals
IONS
$9.4B
| – | – |
-704,855
| Closed | -$25.8M |
|
516
Innospec
IOSP
$2.28B
| – | – |
-155,604
| Closed | -$9.46M |
|
517
Iovance Biotherapeutics
IOVA
$2.87B
| – | – |
-11,000
| Closed | -$90K |
|
518
International Paper
IP
$22B
| – | – |
-640,825
| Closed | -$29.1M |
|
519
IQVIA
IQV
$39.3B
| – | – |
-6,600
| Closed | -$535K |
|
|
IRBT
520
DELISTED
iRobot
IRBT
| – | – |
-449,697
| Closed | -$19.8M |
|
521
Iridium Communications
IRDM
$5.29B
| – | – |
-26,300
| Closed | -$213K |
|
522
Iron Mountain
IRM
$36.1B
| – | – |
-81,400
| Closed | -$3.06M |
|
|
IRS
523
IRSA Inversiones y Representaciones
IRS
$1.26B
| – | – |
-158,145
| Closed | -$2.89M |
|
524
Ironwood Pharmaceuticals
IRWD
$714M
| – | – |
-654,665
| Closed | -$8.71M |
|
525
Intuitive Surgical
ISRG
$134B
| – | – |
-1,540,206
| Closed | -$124M |
|
Similar funds
VGA
Arrowstreet Capital's Q4 2016 Portfolio in Review
As of Q4 2016, Arrowstreet Capital held 3,019 positions worth $27.8B, down 9.3% from $30.6B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Arrowstreet Capital withdrew a net $2.84B in Q4 2016, closing 1,460 positions and reducing 1 holding. Its most notable exit was TSMC, an estimated $954M position sold in full.
By sector, the portfolio is most concentrated in Technology at 0% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.
Against the trend, Arrowstreet Capital opened a new position in ACME Packet Inc worth $236K.
- Arrowstreet Capital's largest Q4 2016 buy was ACME Packet Inc: 9,868 shares worth $236K.
- Arrowstreet Capital's biggest Q4 2016 reduction was Arista Networks, cutting an estimated $8.95K.
- Arrowstreet Capital fully exited TSMC in Q4 2016, selling an estimated $954M.
- Arrowstreet Capital's ten largest holdings make up 15% of its $27.8B portfolio in Q4 2016.
- Arrowstreet Capital opened 1,558 new positions and closed 1,460 in Q4 2016.
- Arrowstreet Capital's portfolio value fell 9.3% quarter-over-quarter to $27.8B.
Based on Arrowstreet Capital's 13F filing for Q4 2016, filed 15 Feb 2017.